Next Article in Journal
Universal Welfare May Be Costly: Evidence from School Meal Programs and Student Fitness in South Korea
Next Article in Special Issue
Empowering Patients to Co-Create a Sustainable Healthcare Value
Previous Article in Journal
What Happens after the Rare Earth Crisis: A Systematic Literature Review
Previous Article in Special Issue
Healthcare and SDGs Governance in Light of the Sustainability Helix Model: Evidence from the African Continent
Article Menu
Issue 5 (March-1) cover image

Export Article

Open AccessArticle
Sustainability 2019, 11(5), 1289; https://doi.org/10.3390/su11051289

From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue

1
Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy
2
Department of Management, “Sapienza” University of Rome, Via del Castro Laurenziano 9, 00161 Roma, Italy
3
Unipegaso, 80132 Naples, Italy
*
Authors to whom correspondence should be addressed.
Received: 29 December 2018 / Revised: 17 February 2019 / Accepted: 26 February 2019 / Published: 1 March 2019
(This article belongs to the Special Issue Sustainability for Healthcare)
  |  
PDF [700 KB, uploaded 4 March 2019]
  |  

Abstract

This work is about how healthcare issues can be reframed from a sustainable and inclusive development perspective. Focusing on the case of orphan drugs and rare diseases, first, a country-based review of the main regulatory approaches to orphan drugs is conducted; then, the main contributions of the literature are reviewed to identify dominant views and the way the problem is more commonly framed. The main findings reveal that the dominant regulatory approaches and theoretical interpretations of the problem are mainly based on economic considerations. However, this does not seem to have led to very satisfactory results. Reflecting upon what the sustainability perspective can highlight with reference to healthcare, substantial connections between the orphan drugs issue and that of neglected diseases are highlighted. These connections suggest reframing the orphan drugs issue as a social equality and inclusiveness problem, hence the need to adopt a sustainable and inclusive development perspective. As a key sustainable development goal (SGD) to be shared by all nations, healthcare should always be approached by putting the principles of sustainable and inclusive development at the core of policy makers’ regulatory choices. Accordingly, we think that the orphan drugs issue, like that of neglected diseases, could be better faced by adopting a social equality and inclusiveness perspective. View Full-Text
Keywords: healthcare; orphan drugs; rare diseases; neglected diseases; sustainable and inclusive development healthcare; orphan drugs; rare diseases; neglected diseases; sustainable and inclusive development
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Saviano, M.; Barile, S.; Caputo, F.; Lettieri, M.; Zanda, S. From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue. Sustainability 2019, 11, 1289.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sustainability EISSN 2071-1050 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top